Clinical Trial Update: ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating RHB-105 versus active comparator for Helicobacter pylori infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Helicobacter Pylori Infection

Drugs mentioned

• RHB-105

Snippet

Sponsor: RedHill Biopharma Limited | Conditions: Helicobacter Pylori Infection, Dyspepsia | Phase 3 | Status: COMPLETED | Results posted: 2020-03-16